Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (56)

« Back to Publications

Vaping and vascular health-emerging risks for Raynaud's, chilblains & Buerger's disease.

Amin M. et al, (2026), Rheumatology (Oxford)

OA10 Using single-cell technology to understand the cellular landscape of colonic disease in systemic sclerosis

Clark KEN. et al, (2026), Rheumatology, 65

Old Techniques Still Have Relevance in Personalized Predictive Medicine.

Clark KEN. and Denton CP., (2026), Arthritis Rheumatol, 78, 285 - 286

A composite biomarker score to predict modified Rodnan skin score in systemic sclerosis: insight from autologous stem cell transplantation international scleroderma trial.

Rodolfi S. et al, (2025), Arthritis Res Ther, 28

Characterization of a pathogenic nonmigratory fibroblast population in systemic sclerosis skin.

Clark KE. et al, (2025), JCI Insight, 10

P124 Autoantibody subgroups in diffuse cutaneous systemic sclerosis show contrasting myofibroblast differentiation by bulk and single-cell RNA sequencing

Clark KEN. et al, (2025), Rheumatology, 64

Elucidating gastric pathology in systemic sclerosis using single-cell RNA sequencing

Clark K. et al, (2025), ARTHRITIS & RHEUMATOLOGY, 77, 3619 - 3621

Integrated Bulk and Single Cell Analysis Confirms Differential Upregulation of the Proton Sensing Receptor GPR68 in Systemic Sclerosis Across Disease Stage and Subset

Clark K. et al, (2025), ARTHRITIS & RHEUMATOLOGY, 77, 1873 - 1875

Validation of a Composite Biomarker Score To Predict Modified Rodnan Skin Score: Insight From Autologous Stem Cell Transplantation International Scleroderma trial

Rodolfi S. et al, (2025), ARTHRITIS & RHEUMATOLOGY, 77, 4852 - 4854

Testing a candidate composite serum protein marker of skin severity in systemic sclerosis.

Roblin E. et al, (2024), Rheumatol Adv Pract, 8

Whole Skin Gene Expression Analysis Identifies Discrete Modules That Differentiate Antinuclear Antibody Subsets in Systemic Sclerosis

Clark K. et al, (2024), ARTHRITIS & RHEUMATOLOGY, 76, 3252 - 3254

Integrated Bulk and Single Cell RNA Sequencing Defines Key Pathways Regulating Myofibroblast Differentiation Across ANA Subgroups in Diffuse Systemic Sclerosis

Clark K. et al, (2024), ARTHRITIS & RHEUMATOLOGY, 76, 5362 - 5363

Analysis of Differential Activation of Lysophosphatidic Acid Regulated Genes in Diffuse and Limited Cutaneous Systemic Sclerosis

Kanitkar M. et al, (2024), ARTHRITIS & RHEUMATOLOGY, 76, 3722 - 3725

Genomic Analysis of Skin Biopsies Differentiates Major Anti-Nuclear Autoantibody Subsets in Limited Cutaneous Systemic Sclerosis

Yee P. et al, (2024), ARTHRITIS & RHEUMATOLOGY, 76, 3734 - 3738

Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups.

Clark KEN. et al, (2023), Ann Rheum Dis, 82, 1568 - 1579

Load More